| Dr Michael Lee Minge Ii, DC | |
|
1323 Highway 394, Suite C, Blountville, TN 37617-4133 | |
| (423) 323-7691 | |
| (423) 279-7850 |
| Full Name | Dr Michael Lee Minge Ii |
|---|---|
| Gender | Male |
| Speciality | Chiropractic |
| Experience | 19 Years |
| Location | 1323 Highway 394, Blountville, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780743971 | NPI | - | NPPES |
| 4278608 | Other | TN | BCBST |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 2421 (Tennessee) | Primary |
| Provider Name | Kevin D Fielden |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1891784146 PECOS PAC ID: 9537192257 Enrollment ID: I20050914000131 |
News Archive
ISTA Pharmaceuticals, Inc., today announced preliminary results from two recently completed studies on its investigational ophthalmic product, T-Pred (prednisolone acetate 1.0% and tobramycin 0.3% ophthalmic suspension). The Company is developing T-Pred as a treatment for inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial ocular infection exists, or there is a risk of bacterial infection.
States with more restrictive alcohol policies and regulations have lower rates of self-reported drunk driving, according to a new study by researchers at the Boston University schools of public health and medicine and the University of Minnesota School of Public Health.
NanoSmart™ Pharmaceuticals, Inc., a California corporation developing novel biopharmaceuticals, is pleased to report that it has received a Notice of Allowance for a US patent on its proprietary cancer tumor targeting technology.
Identifying the molecular profile of a tumour where the primary site is unknown is crucial to the choice of treatment, the 2013 European Cancer Congress, will hear on Monday.
› Verified 9 days ago
| Provider Name | Wellness Way Chiropractic & Massage Therapy Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1639490907 PECOS PAC ID: 5698954816 Enrollment ID: O20110120000397 |
News Archive
ISTA Pharmaceuticals, Inc., today announced preliminary results from two recently completed studies on its investigational ophthalmic product, T-Pred (prednisolone acetate 1.0% and tobramycin 0.3% ophthalmic suspension). The Company is developing T-Pred as a treatment for inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial ocular infection exists, or there is a risk of bacterial infection.
States with more restrictive alcohol policies and regulations have lower rates of self-reported drunk driving, according to a new study by researchers at the Boston University schools of public health and medicine and the University of Minnesota School of Public Health.
NanoSmart™ Pharmaceuticals, Inc., a California corporation developing novel biopharmaceuticals, is pleased to report that it has received a Notice of Allowance for a US patent on its proprietary cancer tumor targeting technology.
Identifying the molecular profile of a tumour where the primary site is unknown is crucial to the choice of treatment, the 2013 European Cancer Congress, will hear on Monday.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Lee Minge Ii, DC Po Box 607, Blountville, TN 37617-0607 Ph: (423) 323-7691 | Dr Michael Lee Minge Ii, DC 1323 Highway 394, Suite C, Blountville, TN 37617-4133 Ph: (423) 323-7691 |
News Archive
ISTA Pharmaceuticals, Inc., today announced preliminary results from two recently completed studies on its investigational ophthalmic product, T-Pred (prednisolone acetate 1.0% and tobramycin 0.3% ophthalmic suspension). The Company is developing T-Pred as a treatment for inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial ocular infection exists, or there is a risk of bacterial infection.
States with more restrictive alcohol policies and regulations have lower rates of self-reported drunk driving, according to a new study by researchers at the Boston University schools of public health and medicine and the University of Minnesota School of Public Health.
NanoSmart™ Pharmaceuticals, Inc., a California corporation developing novel biopharmaceuticals, is pleased to report that it has received a Notice of Allowance for a US patent on its proprietary cancer tumor targeting technology.
Identifying the molecular profile of a tumour where the primary site is unknown is crucial to the choice of treatment, the 2013 European Cancer Congress, will hear on Monday.
› Verified 9 days ago
Dr. Karen M Feeley, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 103 Keystone Dr, Blountville, TN 37617 Phone: 423-323-7691 | |
Fritts Family Chiropractic, Inc. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1323 Highway 394, Ste C, Blountville, TN 37617 Phone: 423-279-7850 Fax: 423-279-7851 | |
Wellness Way Chiropractic & Massage Therapy Pllc Chiropractor Medicare: Medicare Enrolled Practice Location: 1323 Highway 394, Suite C, Blountville, TN 37617 Phone: 423-323-7691 Fax: 423-279-7850 | |
Dr. Zachary Wright, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 3209 Highway 126, Blountville, TN 37617 Phone: 423-354-0100 | |
Dr. David Shannon Fritts, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1323 Hwy 394, Suite C, Blountville, TN 37617 Phone: 423-279-7850 Fax: 423-279-7851 | |
Wellness Way Chiropractic Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 103 Keystone Dr, Blountville, TN 37617 Phone: 423-323-7691 Fax: 423-323-1059 |